Diabetes Drug Class May Hold Promise for Gout Prevention Diabetes Drug Class May Hold Promise for Gout Prevention

Adults with type 2 diabetes prescribed an SGLT2 inhibitor were less likely to develop gout than those prescribed a GLP-1 receptor agonist.Medscape Medical News
Source: Medscape FamilyMedicine Headlines - Category: Primary Care Tags: Diabetes & Endocrinology News Source Type: news